Gert-Jan Botma

发表

Comparative genomics and experimental promoter analysis reveal functional liver-specific elements in mammalian hepatic lipase genes

A. Verhoeven, Diederik van Deursen, Gert-Jan Botma, 2007, BMC Genomics.

Down-regulation of hepatic lipase expression by elevation of cAMP in human hepatoma but not adrenocortical cells

A. Verhoeven, Gert-Jan Botma, H. Jansen, 2008, Molecular and Cellular Endocrinology.

Cloning, expression, and promoter analysis of hepatic lipase derived from human hyperplastic adrenals

A. Verhoeven, Gert-Jan Botma, H. Jansen, 2007, Cell Biochemistry and Biophysics.

Transient induction of a variant hepatic lipase messenger RNA by corticotropic hormone in rat adrenals.

A. Verhoeven, Gert-Jan Botma, H. Jansen, 2006, Metabolism: clinical and experimental.

High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants.

A. Zwinderman, J. Boer, J. Jukema, 2008, Atherosclerosis.

Sterol-regulatory-element binding protein inhibits upstream stimulatory factor-stimulated hepatic lipase gene expression.

A. Verhoeven, M. van Hoek, Diederik van Deursen, 2005, Atherosclerosis.

A common mutation in the lipoprotein lipase gene (N291S) alters the lipoprotein phenotype and risk for cardiovascular disease in patients with familial hypercholesterolemia.

M. Hayden, M. Prins, J. Kastelein, 1998, Circulation.

Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels.

J. Boer, P. de Knijff, J. Kastelein, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor.

A. Verhoeven, Gert-Jan Botma, H. Jansen, 2001, Atherosclerosis.